Canntab Therapeutics Limited

Canntab Therapeutics Limited - PE Ratioverified

CTABF

Price:

$0.0001

Market Cap:

$194.55K

Canntab Therapeutics Limited is a Canadian phytopharmaceutical firm dedicated to pioneering the research and development of sophisticated, pharmaceutical-grade cannabinoid preparations. The company manufactures various oral cannabis medications, including extended-release cannabinoid pills and pellets, rapidly acting cannabidiol formulations, multi-layered modified-release options, quick-dissolving flash-melt products, and dual-layer cannabinoid tablets. These offerings target a broad spectrum of health issues, such as sleep disturbances, post-traumatic stress disorder, social anxiety, various addictions, arthritis, chronic pain, appetite loss and pain linked to cancer therapies, and as an a...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-11-28

Stock Exchange

OTC

Ticker

CTABF

The PE Ratio as of June 2026 (TTM) for Canntab Therapeutics Limited (CTABF) is -0.00

According to Canntab Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -99.90% compared to the average of -1.68 of the last 4 quarters.

Canntab Therapeutics Limited (CTABF) Historical PE Ratio (quarterly & annually)

How has CTABF PE Ratio performed in the past?

The mean historical PE Ratio of Canntab Therapeutics Limited over the last ten years is -9.25. The current -0.00 PE Ratio has changed -98.20% with respect to the historical average. Over the past ten years (40 quarters), CTABF's PE Ratio was at its highest in in the December 2016 quarter at 0.33. The PE Ratio was at its lowest in in the December 2017 quarter at -37.30.

Quarterly (TTM)
Annual

Average

-9.25

Median

-5.24

Minimum

-53.75

Maximum

-0.12

Canntab Therapeutics Limited (CTABF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Canntab Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.96%

Maximum Annual PE Ratio = -0.12

Minimum Annual Increase = -96.23%

Minimum Annual PE Ratio = -53.75

Quarterly (TTM)
Annual
YearPE RatioChange
2022-3.02-60.16%
2021-7.57-25.86%
2020-10.2135.99%
2019-7.510.70%
2018-7.46-86.12%
2017-53.753.96%
2015-1.3256.50%
2014-0.8529.41%
2013-0.65442.39%
2012-0.12-96.23%

Canntab Therapeutics Limited (CTABF) Average PE Ratio

How has CTABF PE Ratio performed in the past?

The current PE Ratio of Canntab Therapeutics Limited (CTABF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.93

5-year avg

-7.15

10-year avg

-9.25

Canntab Therapeutics Limited (CTABF) PE Ratio vs. Peers

How is CTABF’s PE Ratio compared to its peers?

Canntab Therapeutics Limited’s PE Ratio is greater than StateHouse Holdings Inc. (-0.11), less than Cann Group Limited (0.35), less than 1933 Industries Inc. (2.08), greater than Rapid Nutrition PLC (-3.45), greater than LFTD Partners Inc. (-0.08), greater than Revive Therapeutics Ltd. (-1.31), greater than Captiva Verde Wellness Corp. (-7.69), greater than Thunder Energies Corporation (-0.79), less than Resilient Healthcare Corp (0), greater than Rennova Health, Inc. (-0.42),

Build a custom stock screener for Canntab Therapeutics Limited (CTABF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Canntab Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Canntab Therapeutics Limited (CTABF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Canntab Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Canntab Therapeutics Limited's PE Ratio?

How is the PE Ratio calculated for Canntab Therapeutics Limited (CTABF)?

What is the highest PE Ratio for Canntab Therapeutics Limited (CTABF)?

What is the 3-year average PE Ratio for Canntab Therapeutics Limited (CTABF)?

What is the 5-year average PE Ratio for Canntab Therapeutics Limited (CTABF)?

How does the current PE Ratio for Canntab Therapeutics Limited (CTABF) compare to its historical average?